MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival
- 1 January 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 77 (2) , 145-155
- https://doi.org/10.1023/a:1021371028777
Abstract
Crucial event in the metastasis of cancer cells is the secretion of matrix metalloproteinases (MMPs), which are responsible for the degradation of extracellular matrix (ECM). Among them, matrix...Keywords
This publication has 33 references indexed in Scilit:
- Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.Journal of Clinical Investigation, 1997
- Cell surface binding and activation of gelatinase A induced by expression of membrane‐type‐1‐matrix metalloproteinase (MT1‐MMP)FEBS Letters, 1996
- Matrix Metalloproteinases in Breast CancerThe Breast Journal, 1996
- Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic MiceJNCI Journal of the National Cancer Institute, 1995
- Cell surface binding of TIMP‐2 and pro‐MMP‐2/TIMP‐2 complexFEBS Letters, 1995
- Expression and activity of MMPS and their regulators in ovarian cancerInternational Journal of Cancer, 1994
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2Biochemistry, 1992
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980